網頁Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center Gastroenterology Res. 2024 Oct;12 (5):245-251. doi: 10.14740/gr1194. Epub 2024 Oct 4. Authors 網頁We included active Crohn's disease patients who received a standard-dose intravenous induction and at least one subcutaneous ustekinumab 90 mg dose. All enrolled patients …
Stelara Subcutaneous Reviews and User Ratings: Effectiveness, …
網頁2024年8月16日 · Stelara is a brand (trade) name for ustekinumab, an immunosuppressant that helps to reduce inflammation and which may be used for the treatment of plaque psoriasis, psoriatic arthritis, or inflammatory bowel disease. Stelara binds to the p40 protein subunit that is used by two cytokines, IL-12 and IL-23. http://crohnsandcolitis.org.uk/info-support/information-about-crohns-and-colitis/all-information-about-crohns-and-colitis/treatments/ustekinumab grease storage cabinets
Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn…
網頁2024年10月10日 · “The final LTE results of the UNIFI study demonstrated that STELARA can be an effective long-term treatment option for patients living with moderately to severely active ulcerative colitis, including in patients who are biologic-naive,” said UNIFI presenting study author Waqqas Afif, M.D., Associate Professor, Department of Medicine, Division of … 網頁2024年10月25日 · SPRING HOUSE, Pa., Oct. 25, 2024 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA ® (ustekinumab) for the treatment... 網頁2024年10月24日 · A summary of clinical data regarding the measuring of ustekinumab drug levels in patients with Crohn's disease (CD) treated with STELARA® (ustekinumab). Phase 3 UNITI Clinical Trial Program Feagan et al (2016) 6, 7 evaluated the efficacy and safety of STELARA in 3 randomized, double-blind, placebo-controlled phase 3 clinical studies in … choose a restore date